2Seventy Bio Inc
NASDAQ:TSVT

Watchlist Manager
2Seventy Bio Inc Logo
2Seventy Bio Inc
NASDAQ:TSVT
Watchlist
Price: 5 USD Market Closed
Market Cap: 266.2m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+2%
Revenue
Forecast
+29%
Operating Income
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

TSVT Price Targets Summary
2Seventy Bio Inc

Wall Street analysts forecast TSVT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TSVT is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

TSVT Lowest Forecast
Wall Street Target
5.05 USD
1% Upside
TSVT Average Forecast
Wall Street Target
5.1 USD
2% Upside
TSVT Highest Forecast
Wall Street Target
5.25 USD
5% Upside
Lowest
Price Target
5.05 USD
1% Upside
Average
Price Target
5.1 USD
2% Upside
Highest
Price Target
5.25 USD
5% Upside
2Seventy Bio Inc Competitors:
Price Targets
N
4893
Noile-Immune Biotech Inc
175% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
37% Upside
RNA
Avidity Biosciences Inc
121% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
57% Downside
N
4893
Noile-Immune Biotech Inc
175% Upside
688366
Shanghai Haohai Biological Technology Co Ltd
37% Upside
RNA
Avidity Biosciences Inc
121% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
57% Downside
603392
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
10% Downside
INCY
Incyte Corp
17% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
55% Upside

Revenue
Forecast

Revenue Estimate
2Seventy Bio Inc

For the last 5 years the compound annual growth rate for 2Seventy Bio Inc's revenue is -3%. The projected CAGR for the next 3 years is 29%.

-3%
Past Growth
29%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
2Seventy Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
2Seventy Bio Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
What are analyst estimates?

See Also

Summary
TSVT intrinsic value, competitors valuation, and company profile.
DCF Valuation
TSVT stock valuation using Discount Cash Flow valuation method.
Relative Valuation
TSVT stock valuation using valuation multiples.
Wall Street Estimates
TSVT price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
TSVT stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TSVT's stock price target?
Price Target
5.1 USD

According to Wall Street analysts, the average 1-year price target for TSVT is 5.1 USD with a low forecast of 5.05 USD and a high forecast of 5.25 USD.

What is 2Seventy Bio Inc's Revenue forecast?
Projected CAGR
29%

For the last 5 years the compound annual growth rate for 2Seventy Bio Inc's revenue is -3%. The projected CAGR for the next 3 years is 29%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.